[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Fritzberg et al., 1981 - Google Patents

Chemical and biological studies of Tc-99m N, N′-bis (mercaptoacetamido) ethylenediamine: A potential replacement for I-131 iodohippurate

Fritzberg et al., 1981

View PDF @Free from Publisher
Document ID
10104777375664168645
Author
Fritzberg A
Klingensmith W
Whitney W
Kuni C
Publication year
Publication venue
Journal of Nuclear Medicine

External Links

Snippet

Chemical and Biological Studies of Tc-99m N,N'-Bis(mercaptoacetamido)- ethylenediamine: A Potential Replacement for 1-131 lodohi Page 1 Chemical and Biological Studies of Tc-99m N,N'-Bis(mercaptoacetamido)- ethylenediamine: A Potential Replacement for 1-131 …
Continue reading at jnm.snmjournals.org (PDF) (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/0474Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0476Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from monodendate ligands, e.g. sestamibi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody or an immunoglobulin, or a fragment thereof, e.g. a camelised human single domain antibody, or the Fc fragment of an antibody
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/0493Steroids, e.g. cholesterol, testosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/041Heterocyclic compounds
    • A61K51/044Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules

Similar Documents

Publication Publication Date Title
Fritzberg et al. Chemical and biological studies of Tc-99m N, N′-bis (mercaptoacetamido) ethylenediamine: A potential replacement for I-131 iodohippurate
Fritzberg et al. Synthesis and Biological Evaluation of Tc-99m N, N′-Bis (mercaptoacetyl)-2, 3-diaminopropanoate: A Potential Replacement for [131I] o-iodohippurate
John et al. Structure-activity relationships for metal-labeled blood flow tracers: comparison of keto aldehyde bis (thiosemicarbazonato) copper (II) derivatives
Ogawa et al. Development of a novel 99mTc-chelate–conjugated bisphosphonate with high affinity for bone as a bone scintigraphic agent
Yokoyama et al. The design of a pentavalent 99mTc− dimercaptosuccinate complex as a tumor imaging agent
Marques et al. 13-and 14-membered macrocyclic ligands containing methylcarboxylate or methylphosphonate pendant arms: chemical and biological evaluation of their 153Sm and 166Ho complexes as potential agents for therapy or bone pain palliation
US4923969A (en) Preparation of 99m Tc radiopharmaceuticals
Bubeck et al. Technetium-99m labeled renal function and imaging agents: II. Clinical evaluation of 99mTc MAG3 (99mTc mercaptoacetylglycylglycylglycine)
Loberg et al. Membrane transport of Tc-99m-labeled radiopharmaceuticals. I. Brain uptake by passive transport
Shattuck et al. Evaluation of the hepatobiliary excretion of technetium-99m-MAG3 and reconstitution factors affecting radiochemical purity
Baldas et al. Effect of the Tc-nitrido group on the behaviour of 99mTc-radiopharmaceuticals
Fritzberg et al. HPLC analysis of Tc-99m iminodiacetate hepatobiliary agents and a question of multiple peaks: concise communication
Sun et al. In vivo evaluation of copper-64-labeled monooxo-tetraazamacrocyclic ligands
Rajagopalan et al. Preparation, characterization, and biological evaluation of technetium (V) and rhenium (V) complexes of novel heterocyclic tetradentate N3S ligands
Marques et al. 153 Sm and 166 Ho complexes with tetraaza macrocycles containing pyridine and methylcarboxylate or methylphosphonate pendant arms
WO2002009771A1 (en) Radiopharmaceutical for diagnostic imaging containing a technetium-99m nitride heterocomplex
AU2001276677A1 (en) Radiopharmaceutical for diagnostic imaging containing a technetium-99m nitride heterocomplex
Chervu et al. Technetium-99m-labeled p-aminohippuric acid analog: a new renal agent: concise communication
Kasina et al. Simplified preformed chelate protein radiolabeling with technetium-99m mercaptoacetamidoadipoylglycylglycine (N3S-adipate)
Mirković et al. Novel tetradentate diamine dioxime ligands: synthesis, characterization and in vivo behavior of their 99mTc‐complexes
Chakravarty et al. Technetium-99m amino acid chelates: Correlation of their physico-chemical and physiological parameters. Part I.
Djokić et al. Chemical and biological evaluation of 99m Tc (CO) 3 and 99m Tc complexes of some IDA derivatives
Jalilian et al. Development of 111In-DTPA-human polyclonal antibody complex for long-term inflammation/infection detection
Jansholt et al. Catabolism and protein binding of Tc-99m pyridoxylideneglutamate
Baldas et al. Preparation, HPLC studies and biological behaviour of 99mTc-and 99mTcN-radiopharmaceuticals based on quinoline type ligands